Search results
ASCO24: MSD’s ADC shows efficacy in lung and breast tumours
Pharmaceutical Technology via Yahoo Finance· 3 hours agoIn October 2023, the company partnered with Daiichi Sankyo to develop and commercialise three of the...
Agios Pharmaceuticals (AGIO) Surges 6.5%: Is This an Indication of Further Gains?
Zacks via Yahoo Finance· 1 day agoAgios Pharmaceuticals (AGIO) was a big mover last session on higher-than-average trading volume. The...
Teva launches generic version of Novo Nordisk's diabetes drug Victoza
Reuters· 24 hours agoTeva Pharmaceuticals said on Monday it had launched a generic version of Danish drugmaker Novo...
Alimera Sciences shares jump by 77% after being acquired by ANI
Pharmaceutical Technology via Yahoo Finance· 1 day agoANI Pharmaceuticals is broadening its reach into the rare disease space through an acquisition of...
Cheaper Versions of Popular New Weight-Loss Drugs Are Being Developed
Scientific American· 4 days agoBlockbuster weight-loss drugs such as Wegovy could soon become a lot cheaper — and reach more people...
Lawsuit could challenge trust in Ozempic and other popular weight loss drugs
The Conversation via Yahoo News· 5 days agoI’m a health law professor who studies pharmaceutical drug regulation and access to medicines, and...
Jazz Pharmaceuticals' phase 2b trial for suvecaltamide fails to meet objectives By Investing.com
Investing.com· 5 days agoJazz Pharmaceuticals plc (NASDAQ:JAZZ) disclosed top-line results from its Phase 2b clinical trial...
Novo Nordisk’s Wegovy Weight-Loss Drug Gets Approval in China
The Wall Street Journal· 5 hours agoBlockbuster obesity drug Wegovy has been approved in China, opening the door for maker Novo Nordisk...
Jazz Pharmaceuticals’ essential tremor drug falls flat in Phase IIb trial
Clinical Trials Arena via Yahoo Finance· 4 days agoAll other agents are in Phase II or lower. "Jazz Pharmaceuticals’ essential tremor drug falls flat...
Alnylam Shares Soar After Drug Meets Goal in Heart Disease Trial
Bloomberg· 1 day agoHave a confidential tip for our reporters? Alnylam Pharmaceuticals Inc. shares soared after its drug...